↓ Skip to main content

Cochrane Database of Systematic Reviews

Edaravone for acute ischaemic stroke

Overview of attention for article published in Cochrane database of systematic reviews, December 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
8 X users

Citations

dimensions_citation
103 Dimensions

Readers on

mendeley
101 Mendeley
Title
Edaravone for acute ischaemic stroke
Published in
Cochrane database of systematic reviews, December 2011
DOI 10.1002/14651858.cd007230.pub2
Pubmed ID
Authors

Shejun Feng, Qingwei Yang, Ming Liu, Weizheng Li, Wenming Yuan, Shihong Zhang, Bo Wu, Juntao Li

Abstract

Neuroprotection is a promising therapeutic strategy for the treatment of acute ischaemic stroke. Edaravone is a neuroprotective agent that has been widely used in China, and several studies have suggested that it may be beneficial in acute ischaemic stroke.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Unknown 100 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 14%
Researcher 12 12%
Student > Ph. D. Student 11 11%
Professor > Associate Professor 6 6%
Student > Bachelor 6 6%
Other 23 23%
Unknown 29 29%
Readers by discipline Count As %
Medicine and Dentistry 35 35%
Nursing and Health Professions 7 7%
Neuroscience 6 6%
Agricultural and Biological Sciences 4 4%
Computer Science 3 3%
Other 13 13%
Unknown 33 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2016.
All research outputs
#6,858,332
of 25,381,384 outputs
Outputs from Cochrane database of systematic reviews
#8,454
of 12,960 outputs
Outputs of similar age
#56,780
of 250,601 outputs
Outputs of similar age from Cochrane database of systematic reviews
#107
of 214 outputs
Altmetric has tracked 25,381,384 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 12,960 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,601 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 214 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.